Clinical Trial: A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909590) titled 'A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning' on Oct. 16.

Brief Summary: The aim of this study is to generate real-world, consumer reported evidence on the perceived impact of headache relief with Panadol/Dolex on Quality of Life (QoL) and daily functioning.

Study Start Date: Nov., 2026

Study Type: OBSERVATIONAL

Condition: Pain

Intervention: DRUG: Paracetamol

Paracetamol 500 milligram (mg) taken orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: HALEON

Disclaimer: Curated by HT Syndication....